Open
X

Posts Tagged 'FH'

Your Doctor Prescribed a Medicine, But Will You Get It?

Seth J. Baum, MD In 2013 Dr. Tom Frieden, Director of the CDC, judiciously proclaimed that “even one preventable death is one too many.” Just three years later we are.. read more

Accessing PCSK9 Inhibitors: An Ongoing Bottleneck for Patients and Their Doctors

by Seth J. Baum MD PCSK9 inhibitors are the most significant advance in the management of elevated cholesterol in the last 3 decades. These injectable medications are indisputably revolutionary: They.. read more

Response to Matt Perrone‘s April 20th Associated Press Piece on PCSK9 Inhibitors

by Seth J. Baum MD I was fortunate to have the opportunity to speak at length with Matt Perrone prior to his submitting an April 20th article on the PSCK9.. read more

FH Foundation’s National FH Registry Illustrates U.S. FH Population’s Risk for Early CHD

Posted on April 20th, 2016 · Posted in cardiology, familial hypercholesterolemia, FH, health, lipids, medication, medicine, News, statins

Important research recently published in the American Heart Association’s journals illustrates that the cardiovascular disease burden and treatment patterns among patients with familial hypercholesterolemia (FH) in the US remain poorly.. read more

PCSK9 Inhibitors: Why Are They Under-Prescribed?

by Seth J. Baum, MD A recent article by Caroline Humer and Ransdell Pierson for Reuters reported on the unexpectedly paltry number of prescriptions for PCSK9 inhibitors, the revolutionary cholesterol.. read more

#Know FH – The 2015 FH Summit

Posted on September 28th, 2015 · Posted in cardiology, Events, familial hypercholesterolemia, FH, lipids, News

by Seth J. Baum, MD Flying back from the FH Foundation’s third annual FH Summit I was suffused by assorted feelings and thoughts. I attend many meetings; yet, this one.. read more

Caution: Economists, Not Doctors Might be Prescribing Your Medicine

Posted on September 17th, 2015 · Posted in cardiology, Events, FH, lipids, medication, News

by Seth J. Baum, MD It’s National Cholesterol Education Month and we have fittingly entered a new era in lipid management. We now know that elevated LDL cholesterol causes heart.. read more

FDA Gives Premarket Approval for Modification of LDL Indications for Use of Lipoprotein Apheresis System

Posted on July 21st, 2015 · Posted in cardiology, News

by Seth J. Baum, MD, FACC, FACPM, FAHA, FNLA The FDA has granted premarket approval to Kaneka Pharma America’s application requesting approval for modification of the indications for use of.. read more